Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab

A high concentration of circulating vascular endothelial growth factor (VEGF) in cancer patients is associated with an aggressive tumor phenotype. Here, serum levels of 27 cytokines and blood cell counts were assessed in breast cancer patients receiving neoadjuvant chemotherapy with or without bevac...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncoimmunology
Prif Awduron: Jabeen, Shakila, Zucknick, Manuela, Nome, Marianne, Dannenfelser, Ruth, Fleischer, Thomas, Kumar, Surendra, Lüders, Torben, von der Lippe Gythfeldt, Hedda, Troyanskaya, Olga, Kyte, Jon Amund, Børresen-Dale, Anne-Lise, Naume, Bjørn, Tekpli, Xavier, Engebraaten, Olav, Kristensen, Vessela
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Taylor & Francis 2018
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6205029/
https://ncbi.nlm.nih.gov/pubmed/30377556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1457598
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg